| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.3M | +110.1% |
| SG&A Expense | $4.7M | -27.5% |
| Interest Expense | -$166K | -104.8% |
| Net Income | -$7.9M | +34.5% |
| EPS (Basic) | -$0.51 | +20.3% |
| EPS (Diluted) | -$0.51 | +20.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $2.9M | -40.6% |
| Total Assets | $2.9M | -40.7% |
| Current Liabilities | $723K | +29.6% |
| Total Liabilities | $723K | +29.6% |
| Stockholders' Equity | $2.2M | -49.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | -22.7% |
| Financing Cash Flow | $3.8M | -56.8% |